Author:
Gugler R.,Fr�scher W.,Eichelbaum M.,Hildenbrand G.
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),Neurology
Reference27 articles.
1. Albert, K. S., Sakmar, E., Hallmark, M. R., Weidler, D., Wagner, J. G.: Bioavailability of diphenylhydantoin. Clin. Pharmacol. Ther. 16, 727?735 (1974)
2. Arnold, K., Gerber, N.: The rate of decline of diphenylhydantoin in human plasma. Clin. Pharmacol. Ther. 11, 121?134 (1970)
3. Arnold, K., Gerber, N., Levy, G.: Absorption and dissolution studies in sodium diphenylhydantoin capsules. Canad. J. Pharm. Sci. 5, 89?92 (1970)
4. Atkinson, A. J., MacGee, J., Strong, J., Garteiz, D., Gaffney, T. E.: Identification of 5-meta-hydroxyphenyl-5-phenylhydantoin as a metabolite of diphenylhydantoin. Biochem. Pharmacol. 19, 2483?2491 (1970)
5. Berlin, A., Agurell, S., Borgå, O., Lund, L., Sjöqvist, F.: Micromethod for the determination of diphenylhydantoin in plasma and cerebrospinal fluid. A comparison between a gas chromatographic and a spectrophotometric method. Scand. J. clin. Lab. Invest. 29, 281?287 (1972)
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献